BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33590974)

  • 1. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
    Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
    Prokopchuk O; Grünwald B; Nitsche U; Jäger C; Prokopchuk OL; Schubert EC; Friess H; Martignoni ME; Krüger A
    BMC Cancer; 2018 Feb; 18(1):128. PubMed ID: 29394913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a cancer cachexia risk score for digestive tract cancer patients before abdominal surgery.
    Tan S; Xu J; Wang J; Zhang Z; Li S; Yan M; Tang M; Liu H; Zhuang Q; Xi Q; Meng Q; Jiang Y; Wu G
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):891-902. PubMed ID: 36880286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triceps skinfold-albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study.
    Yin L; Cui J; Lin X; Li L; Li N; Fan Y; Zhang L; Liu J; Chong F; Lu Z; Wang C; Liang T; Liu X; Deng L; Yang M; Yu J; Wang X; Cong M; Li Z; Weng M; Yao Q; Jia P; Guo Z; Li W; Song C; Shi H; Xu H
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):517-533. PubMed ID: 36567070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study.
    Huang JX; Zhang X; Tang M; Zhang Q; Deng L; Song CH; Li W; Shi HP; Cong MH
    BMC Cancer; 2024 Mar; 24(1):293. PubMed ID: 38438901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden.
    Hong N; Yoon HJ; Lee YH; Kim HR; Lee BW; Rhee Y; Kang ES; Cha BS; Lee HC
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1207-14. PubMed ID: 26765580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle.
    Johns N; Hatakeyama S; Stephens NA; Degen M; Degen S; Frieauff W; Lambert C; Ross JA; Roubenoff R; Glass DJ; Jacobi C; Fearon KC
    PLoS One; 2014; 9(1):e83618. PubMed ID: 24404136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases-1 in the prognostic evaluation of primary breast cancer patients.
    Würtz SØ; Christensen IJ; Schrohl AS; Mouridsen H; Lademann U; Jensen V; Brünner N
    Mol Cell Proteomics; 2005 Apr; 4(4):483-91. PubMed ID: 15640527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients.
    Oh WK; Vargas R; Jacobus S; Leitzel K; Regan MM; Hamer P; Pierce K; Brown-Shimer S; Carney W; Ali SM; Kantoff PW; Lipton A
    Cancer; 2011 Feb; 117(3):517-25. PubMed ID: 20862742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
    Luvián-Morales J; Delgadillo-González M; Castro-Eguiluz D; Oñate-Ocaña LF; Cetina-Pérez L
    Jpn J Clin Oncol; 2024 Apr; 54(4):416-423. PubMed ID: 38146122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer).
    Poisson J; Martinez-Tapia C; Heitz D; Geiss R; Albrand G; Falandry C; Gisselbrecht M; Couderc AL; Boulahssass R; Liuu E; Boudou-Rouquette P; Chah Wakilian A; Gaxatte C; Pamoukdjian F; de Decker L; Antoine V; Cattenoz C; Solem-Laviec H; Guillem O; Medjenah H; Natella PA; Canouï-Poitrine F; Laurent M; Paillaud E
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1477-1488. PubMed ID: 34519440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
    BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients.
    Wallengren O; Lundholm K; Bosaeus I
    Support Care Cancer; 2013 Jun; 21(6):1569-77. PubMed ID: 23314651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the diagnostic criteria from the Asian Working Group for Cachexia in advanced cancer.
    Sakaguchi T; Maeda K; Takeuchi T; Mizuno A; Kato R; Ishida Y; Ueshima J; Shimizu A; Amano K; Mori N
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):370-379. PubMed ID: 38115133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
    da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
    J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
    Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cachexia staging score predicts survival in patients with cancer who receive palliative care.
    Ueshima J; Maeda K; Shimizu A; Nagano A; Ishida Y; Takeuchi T; Nonogaki T; Matsuyama R; Yamanaka Y; Murotani K; Mori N
    Nutrition; 2023 Feb; 106():111880. PubMed ID: 36436335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.